Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.
Arndt C, Bergmann R, Striese F, Merkel K, Máthé D, Loureiro LR, Mitwasi N, Kegler A, Fasslrinner F, González Soto KE, Neuber C, Berndt N, Kovács N, Szöllősi D, Hegedűs N, Tóth G, Emmermann JP, Harikumar KB, Kovacs T, Bachmann M, Feldmann A.
Arndt C, et al. Among authors: merkel k.
Cancers (Basel). 2022 Apr 14;14(8):1996. doi: 10.3390/cancers14081996.
Cancers (Basel). 2022.
PMID: 35454902
Free PMC article.